Pharma stares down another term without a friend in the White House

Regardless of how the next year and a half shakes out, it seems increasingly likely that the pharmaceutical industry is going to have an adversary in the White House come 2025.Why it matters: Drugmakers are still reeling from Democrats' new law allowing Medicare to negotiate the price of drugs, but both President Biden and former President Trump are vowing even harsher crackdowns…